Diclofenac Sodium
Product Images NDC 50436-0676

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 50436-0676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure Image (Diclofenac Sodium Extended Release Tablets 1)

Structure Image (Diclofenac Sodium Extended Release Tablets 1)
Chemical structure of Diclofenac Sodium showing two benzene rings, two chlorine atoms, an amine group, and a carboxylate group with sodium.*
FDA Label Image

Side Effects Image (Diclofenac Sodium Extended Release Tablets 2)

Side Effects Image (Diclofenac Sodium Extended Release Tablets 2)
Text panel listing serious and other side effects of Diclofenac Sodium. Serious side effects include heart attack, stroke, heart failure, kidney problems, bleeding in stomach/intestine, anemia, severe skin and allergic reactions, liver failure, and asthma attacks. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*
FDA Label Image

Label Image (Lbl504360676)

Label Image (Lbl504360676)
Diclofenac Sodium Extended-Release 100 mg, 30 tablets per bottle, by Unit Dose Services. The label includes storage instructions, manufacturer details (Dexcel Ltd., Israel), lot number 247434, expiration date 07/31/17, and is marked for prescription use only (RX ONLY). The label is primarily black text on a white background.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.